Post-traumatic Stress Disorder
📧 Sign up to get email alerts when something new happens for Post-traumatic Stress Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-08-18FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for paroxetine submitted by Padagis US LLC. This action represents an additional regulatory appr…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: HIRREM in Military Personnel [NA]
Clinical trial update for HIRREM in military personnel addressing stress disorders and post-traumatic stress; study completed with results p…
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Brief Cognitive Behavioral Conjoint Therapy for PTSD With Adjunctive Intranasal Oxytocin [Phase 2]
Phase 2 trial evaluating Brief Cognitive Behavioral Conjoint Therapy for PTSD with adjunctive intranasal oxytocin; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder [Phase 2]
Phase 2 clinical trial evaluating psilocybin for treatment-resistant post-traumatic stress disorder.
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Cannabidiol as a Treatment for AUD Comorbid With PTSD [Phase 1, Phase 2]
A clinical trial investigating cannabidiol for alcohol use disorder comorbid with PTSD has completed Phase 1 and Phase 2; results were poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: A Non-Pharmacological Method for Enhancing Sleep in PTSD [NA]
A completed clinical trial evaluating a non-pharmacological method to improve sleep in individuals with PTSD and sleep problems.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD [Phase 2]
Phase 2 trial evaluating a kappa opioid receptor antagonist for treating alcohol use disorder with comorbid PTSD; study terminated with resu…
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Evaluation of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans [Phase 2]
A Phase 2 clinical trial evaluating psilocybin-assisted psychotherapy for post-traumatic stress disorder in military veterans.
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Brief Treatment for Posttraumatic Stress Disorder [NA]
Clinical trial update for Brief Treatment for Posttraumatic Stress Disorder has completed; results posted in 2023.
-
CLINICAL_TRIALS research · 2023-05-12Clinical Trial Update: A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health [Phase 4]
A Phase 4 retrospective effectiveness trial evaluated ketamine-assisted psychotherapy in adults with depression and anxiety (and PTSD as lis…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Accelerated TMS to a Novel Brain Target in MDD and PTSD [NA]
Clinical trial update on accelerated TMS targeting a novel brain region for major depressive disorder and post-traumatic stress disorder; st…
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Family-Authored ICU Diaries to Reduce Fear in Patients Experiencing a Cardiac Arrest (FAID Fear) [NA]
Completed clinical trial evaluating family-authored ICU diaries to reduce fear in patients experiencing cardiac arrest and post-traumatic st…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Psychological Symptoms and Families of COVID-19 Patients [NA]
Clinical trial update on psychological symptoms in families of COVID-19 patients, including post-intensive care unit syndrome and PTSD.
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Progesterone Effect on Individuals Diagnoses With AD and PTSD. [Phase 2, Phase 3]
Phase 2/3 trial evaluating progesterone effects in individuals with alcohol dependence and PTSD; study completed with results posted in 2023…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD) [Phase 2]
A Phase 2 clinical trial for alcohol use disorder with comorbid post-traumatic stress disorder has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD [Phase 2, Phase 3]
Aptinyx evaluated 50 mg NYX-783 daily for PTSD in phase 2/3 trials; the study status is terminated, with safety and efficacy data available.
-
FDA approval · 2023-03-31FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Granules Pharmaceuticals' sertraline hydrochloride generic product, enabling its marketing in th…
-
FDA approval · 2023-03-23FDA Approved: PAROXETINE — Supplemental Application (Modavar Pharmaceuticals LLC)
FDA approved a supplemental application for generic paroxetine filed by Modavar Pharmaceuticals LLC under ANDA212645.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study [Phase 3]
A Phase 3 effectiveness study evaluating reconsolidation blockade for trauma-related disorders after Paris attacks in PTSD patients, complet…
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Nitrous Oxide for PTSD [Phase 2]
Phase 2 trial of nitrous oxide for PTSD was terminated with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Phase II Study of BNC210 in PTSD [Phase 2]
Phase II study of BNC210 in post-traumatic stress disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury. [Phase 2]
Preliminary effectiveness results from a Phase 2 trial of MDMA-assisted therapy for Israeli veterans with PTSD and moral injury are reported…
-
CLINICAL_TRIALS withdrawal · 2023-02-08Clinical Trial Update: Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD [Phase 2, Phase 3]
Clinical trial investigating D-cycloserine with imagery rescripting for subclinical PTSD has been withdrawn after Phase 2/3.
-
CLINICAL_TRIALS trial_result · 2023-02-03Clinical Trial Update: Management of Chronic Pain and PTSD in Gulf War Veterans With tDCS+Prolonged Exposure [NA]
Completed clinical trial evaluating transcranial direct current stimulation (tDCS) combined with prolonged exposure therapy for chronic pain…
-
FDA approval · 2023-01-31FDA Approved: PAROXETINE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for paroxetine from ANI Pharmaceuticals, indicating an approved change to the product (e.g., lab…